These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 126502)

  • 21. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study.
    Meyrick B; Gamble W; Reid L
    Am J Physiol; 1980 Nov; 239(5):H692-702. PubMed ID: 6449154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats.
    Mitani Y; Maruyama K; Sakurai M
    Circulation; 1997 Jul; 96(2):689-97. PubMed ID: 9244244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension.
    van Suylen RJ; Smits JF; Daemen MJ
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1423-8. PubMed ID: 9603118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic overcirculation-induced pulmonary arterial hypertension in aorto-caval shunt.
    Rungatscher A; Linardi D; Milani E; Ucci G; Nicolato E; Merigo F; Salvetti B; Mazzucco A; Luciani GB; Faggian G
    Microvasc Res; 2014 Jul; 94():73-9. PubMed ID: 24862700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary hypertension and arterial changes in calves with a systemic-to-left pulmonary artery connection.
    Fasules JW; Tryka F; Chipman CW; Van Devanter SH
    J Appl Physiol (1985); 1994 Aug; 77(2):867-75. PubMed ID: 8002541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of captopril on pulmonary vascular remodeling induced by left-to-right shunt in rats].
    Li M; Zhou TF; Liu HM; Hua YM; Wang XM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):242-5. PubMed ID: 16608085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxysafflor yellow A (HSYA) attenuates hypoxic pulmonary arterial remodelling and reverses right ventricular hypertrophy in rats.
    Li L; Dong P; Hou C; Cao F; Sun S; He F; Song Y; Li S; Bai Y; Zhu D
    J Ethnopharmacol; 2016 Jun; 186():224-233. PubMed ID: 27063983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary artery remodeling and pulmonary hypertension after exposure to hyperoxia for 7 days. A morphometric and hemodynamic study.
    Jones R; Zapol WM; Reid L
    Am J Pathol; 1984 Nov; 117(2):273-85. PubMed ID: 6238536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A morphological study of primary pulmonary hypertension--an analysis of six autopsy cases.
    Wang B; Cui S; Liu X; Li C; Qiu H; Shi J; Li T
    Chin Med Sci J; 1991 Sep; 6(3):178-81. PubMed ID: 1793883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A morphological study of primary pulmonary hypertension: an analysis of five autopsies].
    Wang BL
    Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):125-7. PubMed ID: 1914019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased pulmonary artery elastolytic activity in adult rats with monocrotaline-induced progressive hypertensive pulmonary vascular disease compared with infant rats with nonprogressive disease.
    Todorovich-Hunter L; Dodo H; Ye C; McCready L; Keeley FW; Rabinovitch M
    Am Rev Respir Dis; 1992 Jul; 146(1):213-23. PubMed ID: 1626806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The inhibitory effects of Radix Astragali on hypoxic pulmonary hypertension of rats].
    Xi S; Ruan Y; Zhang L
    Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):236-8. PubMed ID: 9275660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension.
    Schermuly RT; Kreisselmeier KP; Ghofrani HA; Samidurai A; Pullamsetti S; Weissmann N; Schudt C; Ermert L; Seeger W; Grimminger F
    Circ Res; 2004 Apr; 94(8):1101-8. PubMed ID: 15031263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary pulmonary hypertension in infancy: report of two autopsy cases.
    Fujinami M; Nishikawa T; Kajita A; Takao A
    Acta Cardiol; 1989; 44(1):19-28. PubMed ID: 2711795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arterial changes in Crotalaria spectabilis-induced pulmonary hypertension in rats.
    Hislop A; Reid L
    Br J Exp Pathol; 1974 Apr; 55(2):153-63. PubMed ID: 4835803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin attenuates pulmonary arterial hypertension in rats by reducing plasma 5-hydroxytryptamine levels.
    Shen L; Shen J; Pu J; He B
    Cell Biochem Biophys; 2011 Sep; 61(1):23-31. PubMed ID: 21327581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of chymase-dependent angiotensin II formation in monocrotaline-induced pulmonary hypertensive rats.
    Kishi K; Jin D; Takai S; Muramatsu M; Katayama H; Tamai H; Miyazaki M
    Pediatr Res; 2006 Jul; 60(1):77-82. PubMed ID: 16690960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of pulmonary arterial changes in rats fed Crotalaria spectabilis.
    Meyrick B; Reid L
    Am J Pathol; 1979 Jan; 94(1):37-50. PubMed ID: 153714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.